Covid-19

SARS-CoV-2 vaccines: a triumph of science and collaboration

Roughly 1 year after the first case of COVID-19 was identified and less than 1 year after the sequencing of SARS-CoV-2, multiple SARS-CoV-2 vaccines with demonstrated safety and efficacy in phase III clinical trials are available. The most promising …

The prevalence and impact of pre-existing sleep disorder diagnoses and objective sleep parameters in patients hospitalized for COVID-19

STUDY OBJECTIVES: Obstructive sleep apnea (OSA) and other sleep disorders overlap with co-morbidities associated with poor outcomes related to SARS-CoV-2 infection. However, the prevalence of OSA among patients hospitalized for COVID-19 and …